J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Craigo, J. K.
Right arrow Articles by Montelaro, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Craigo, J. K.
Right arrow Articles by Montelaro, R. C.
Agricola
Right arrow Articles by Craigo, J. K.
Right arrow Articles by Montelaro, R. C.
Journal of General Virology (2002), 83, 1353-1359.
© 2002 Society for General Microbiology


Animal: RNA Viruses

Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication

Jodi K. Craigo1, Caroline Lerouxb,1, Laryssa Howe1, Jonathan D. Steckbeck1, Sheila J. Cook2, Charles J. Issel2 and Ronald C. Montelaro1

Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA1
Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington, KY 40546, USA2

Author for correspondence: Ronald Montelaro. Fax +1 412 383 8859. e-mail rmont{at}pitt.edu

The genetic variation of equine infectious anaemia virus (EIAV) clearly affects the antigenic properties of the viral envelope; however, effects on immunogenicity remain undefined, although widely assumed. Here, the immunogenicity is reported of a novel, neutralization-resistant, pony-isolate envelope EIAVPV564{Delta}PND that contains a 14-residue deletion in the designated principal neutralizing domain (PND) of the gp90 protein. Two ponies inoculated with a chimeric virus, EIAV{Delta}PND, containing the EIAVPV564{Delta}PND envelope in a reference provirus strain, remained asymptomatic through 14 months post-inoculation, producing high steady-state levels of envelope-specific antibodies but no detectable serum-neutralizing antibodies. Consequent dexamethasone-induced immune suppression produced characteristic EIA that resolved concomitantly with the development of high-titre, strain-specific, neutralizing antibodies and a 100-fold reduction in steady-state virus loads. These results demonstrate: natural variations in the EIAV envelope have profound effects on both antigenic and immunogenic properties; the PND is not required for neutralizing antibody responses; and transient immune suppression can enhance established host immunity to achieve more effective control of steady-state lentivirus replication.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. K. Craigo, B. Zhang, S. Barnes, T. L. Tagmyer, S. J. Cook, C. J. Issel, and R. C. Montelaro
Envelope variation as a primary determinant of lentiviral vaccine efficacy
PNAS, September 18, 2007; 104(38): 15105 - 15110.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
T. L. Tagmyer, J. K. Craigo, S. J. Cook, C. J. Issel, and R. C. Montelaro
Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus
J. Gen. Virol., April 1, 2007; 88(4): 1324 - 1336.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. K. Craigo, F. Li, J. D. Steckbeck, S. Durkin, L. Howe, S. J. Cook, C. Issel, and R. C. Montelaro
Discerning an Effective Balance between Equine Infectious Anemia Virus Attenuation and Vaccine Efficacy
J. Virol., March 1, 2005; 79(5): 2666 - 2677.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
L. Howe, J. K. Craigo, C. J. Issel, and R. C. Montelaro
Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain
J. Gen. Virol., January 1, 2005; 86(1): 139 - 149.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Howe, C. Leroux, C. J. Issel, and R. C. Montelaro
Equine Infectious Anemia Virus Envelope Evolution In Vivo during Persistent Infection Progressively Increases Resistance to In Vitro Serum Antibody Neutralization as a Dominant Phenotype
J. Virol., October 2, 2002; 76(21): 10588 - 10597.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2002 by the Society for General Microbiology.